Interventional Oncology Ablation Market Report: Trends, Forecast and Competitive Analysis to 2030
2 – 3 business days after placing order
Interventional Oncology Ablation Trends and Forecast
The future of the global interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets. The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Interventional Oncology Ablation by Segment
The study includes a forecast for the global interventional oncology ablation by technology, indication, end use, and region.
Interventional Oncology Ablation Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies interventional oncology ablation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the interventional oncology ablation companies profiled in this report include-
Lucintel forecasts that lung will remain the largest segment over the forecast period.
Within this market, hospital & clinic will remain larger segment over the forecast period.
North America will remain the largest region over the forecast period.
Features of the Global Interventional Oncology Ablation Market
Market Size Estimates: Interventional oncology ablation market size estimation in terms of value ($M).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Interventional oncology ablation market size by technology, indication, end use, and region in terms of value ($M).
Regional Analysis: Interventional oncology ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technologies, indications, end uses, and regions for the interventional oncology ablation market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the interventional oncology ablation market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the interventional oncology ablation market size?
Answer: The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030.
Q2. What is the growth forecast for interventional oncology ablation market?
Answer: The global interventional oncology ablation market is expected to grow with a CAGR of 8.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the interventional oncology ablation market?
Answer: The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.
Q4. What are the major segments for interventional oncology ablation market?
Answer: The future of the interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets.
Q5. Who are the key interventional oncology ablation market companies?
Answer: Some of the key interventional oncology ablation companies are as follows:
Answer: Lucintel forecasts that lung will remain the largest segment over the forecast period.
Q7. In interventional oncology ablation market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the interventional oncology ablation market by technology (radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation ablation), indication (liver cancer, kidney cancer, lung cancer, and others), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Interventional Oncology Ablation Market, Interventional Oncology Ablation Market Size, Interventional Oncology Ablation Market Growth, Interventional Oncology Ablation Market Analysis, Interventional Oncology Ablation Market Report, Interventional Oncology Ablation Market Share, Interventional Oncology Ablation Market Trends, Interventional Oncology Ablation Market Forecast, Interventional Oncology Ablation Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Interventional Oncology Ablation Trends and Forecast
The future of the global interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets. The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Interventional Oncology Ablation by Segment
The study includes a forecast for the global interventional oncology ablation by technology, indication, end use, and region.
Interventional Oncology Ablation Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Irreversible Electroporation Ablation
- Liver Cancer
- Kidney Cancer
- Lung Cancer
- Others
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies interventional oncology ablation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the interventional oncology ablation companies profiled in this report include-
- Boston Scientific Corporation
- Johnson & Johnson
- Medtronic
- Varian Medical Systems
- EDAP TMS
- AngioDynamics
- CASCINATION
- Merit Medical Systems
- STARmed
- Biomedical
Lucintel forecasts that lung will remain the largest segment over the forecast period.
Within this market, hospital & clinic will remain larger segment over the forecast period.
North America will remain the largest region over the forecast period.
Features of the Global Interventional Oncology Ablation Market
Market Size Estimates: Interventional oncology ablation market size estimation in terms of value ($M).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Interventional oncology ablation market size by technology, indication, end use, and region in terms of value ($M).
Regional Analysis: Interventional oncology ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technologies, indications, end uses, and regions for the interventional oncology ablation market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the interventional oncology ablation market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the interventional oncology ablation market size?
Answer: The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030.
Q2. What is the growth forecast for interventional oncology ablation market?
Answer: The global interventional oncology ablation market is expected to grow with a CAGR of 8.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the interventional oncology ablation market?
Answer: The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.
Q4. What are the major segments for interventional oncology ablation market?
Answer: The future of the interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets.
Q5. Who are the key interventional oncology ablation market companies?
Answer: Some of the key interventional oncology ablation companies are as follows:
- Boston Scientific Corporation
- Johnson & Johnson
- Medtronic
- Varian Medical Systems
- EDAP TMS
- AngioDynamics
- CASCINATION
- Merit Medical Systems
- STARmed
- Biomedical
Answer: Lucintel forecasts that lung will remain the largest segment over the forecast period.
Q7. In interventional oncology ablation market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the interventional oncology ablation market by technology (radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation ablation), indication (liver cancer, kidney cancer, lung cancer, and others), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Interventional Oncology Ablation Market, Interventional Oncology Ablation Market Size, Interventional Oncology Ablation Market Growth, Interventional Oncology Ablation Market Analysis, Interventional Oncology Ablation Market Report, Interventional Oncology Ablation Market Share, Interventional Oncology Ablation Market Trends, Interventional Oncology Ablation Market Forecast, Interventional Oncology Ablation Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL INTERVENTIONAL ONCOLOGY ABLATION MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Interventional Oncology Ablation Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Interventional Oncology Ablation Market by Technology
3.3.1: Radiofrequency Ablation
3.3.2: Microwave Ablation
3.3.3: Cryoablation
3.3.4: Irreversible Electroporation Ablation
3.4: Global Interventional Oncology Ablation Market by Indication
3.4.1: Liver Cancer
3.4.2: Kidney Cancer
3.4.3: Lung Cancer
3.4.4: Others
3.5: Global Interventional Oncology Ablation Market by End Use
3.5.1: Hospitals & Clinics
3.5.2: Ambulatory Surgical Centers
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Interventional Oncology Ablation Market by Region
4.2: North American Interventional Oncology Ablation Market
4.2.1: North American Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
4.2.2: North American Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
4.3: European Interventional Oncology Ablation Market
4.3.1: European Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
4.3.2: European Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
4.4: APAC Interventional Oncology Ablation Market
4.4.1: APAC Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
4.4.2: APAC Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
4.5: ROW Interventional Oncology Ablation Market
4.5.1: ROW Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
4.5.2: ROW Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Interventional Oncology Ablation Market by Technology
6.1.2: Growth Opportunities for the Global Interventional Oncology Ablation Market by Indication
6.1.3: Growth Opportunities for the Global Interventional Oncology Ablation Market by End Use
6.1.4: Growth Opportunities for the Global Interventional Oncology Ablation Market by Region
6.2: Emerging Trends in the Global Interventional Oncology Ablation Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Interventional Oncology Ablation Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Interventional Oncology Ablation Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Boston Scientific Corporation
7.2: Johnson & Johnson
7.3: Medtronic
7.4: Varian Medical Systems
7.5: EDAP TMS
7.6: AngioDynamics
7.7: CASCINATION
7.8: Merit Medical Systems
7.9: STARmed
7.10: Biomedical
2. GLOBAL INTERVENTIONAL ONCOLOGY ABLATION MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Interventional Oncology Ablation Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Interventional Oncology Ablation Market by Technology
3.3.1: Radiofrequency Ablation
3.3.2: Microwave Ablation
3.3.3: Cryoablation
3.3.4: Irreversible Electroporation Ablation
3.4: Global Interventional Oncology Ablation Market by Indication
3.4.1: Liver Cancer
3.4.2: Kidney Cancer
3.4.3: Lung Cancer
3.4.4: Others
3.5: Global Interventional Oncology Ablation Market by End Use
3.5.1: Hospitals & Clinics
3.5.2: Ambulatory Surgical Centers
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Interventional Oncology Ablation Market by Region
4.2: North American Interventional Oncology Ablation Market
4.2.1: North American Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
4.2.2: North American Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
4.3: European Interventional Oncology Ablation Market
4.3.1: European Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
4.3.2: European Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
4.4: APAC Interventional Oncology Ablation Market
4.4.1: APAC Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
4.4.2: APAC Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
4.5: ROW Interventional Oncology Ablation Market
4.5.1: ROW Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
4.5.2: ROW Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Interventional Oncology Ablation Market by Technology
6.1.2: Growth Opportunities for the Global Interventional Oncology Ablation Market by Indication
6.1.3: Growth Opportunities for the Global Interventional Oncology Ablation Market by End Use
6.1.4: Growth Opportunities for the Global Interventional Oncology Ablation Market by Region
6.2: Emerging Trends in the Global Interventional Oncology Ablation Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Interventional Oncology Ablation Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Interventional Oncology Ablation Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Boston Scientific Corporation
7.2: Johnson & Johnson
7.3: Medtronic
7.4: Varian Medical Systems
7.5: EDAP TMS
7.6: AngioDynamics
7.7: CASCINATION
7.8: Merit Medical Systems
7.9: STARmed
7.10: Biomedical
